ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

36,103Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 680

$2.52M Total Retail Price of All Prescriptions

Rank: 3 out of 680

1,222 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 1,222 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

13% of this provider’s 1,222 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 27,484 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 1,220 983 1 1
SIMVASTATIN 917 774 2 3
METFORMIN HCL 917 740 2 8
FUROSEMIDE 898 729 4 6
LEVOTHYROXINE SODIUM 838 659 5 2
ATORVASTATIN CALCIUM 679 464 6 11
LISINOPRIL 612 476 7 5
HYDROCODONE-ACETAMINOPHEN 605 387 S3 8 4
OMEPRAZOLE 585 431 9 7
NEXIUM 538 342 10 16
MIRTAZAPINE 518 442 11 78
TRAZODONE HCL 515 414 12 48
DONEPEZIL HCL 508 475 13 27
CRESTOR 496 416 14 25
METOPROLOL TARTRATE 473 384 15 12
ESCITALOPRAM OXALATE 454 381 16 45
RISPERIDONE 443 303 17 80
QUETIAPINE FUMARATE 422 306 18 64
ZOLPIDEM TARTRATE 412 263 19 17
WARFARIN SODIUM 402 320 20 20
METOPROLOL SUCCINATE 381 338 21 13
CITALOPRAM HBR 364 264 22 22
MELOXICAM 347 293 23 24
TRICOR 331 259 24 98
SERTRALINE HCL 320 240 25 28
NAMENDA 317 295 26 35
GABAPENTIN 314 223 27 15
HYDROCHLOROTHIAZIDE 309 242 28 9
CLOPIDOGREL 303 242 29 26
ATENOLOL 302 239 30 19
GLIMEPIRIDE 295 224 31 29
CARVEDILOL 285 231 32 23
DIOVAN 283 251 33 31
POTASSIUM CHLORIDE 277 217 34 14
TAMSULOSIN HCL 277 182 34 34
KLOR-CON M20 265 207 36 61
BENZTROPINE MESYLATE 265 122 R 36 137
LACTULOSE 263 192 38 92
CYMBALTA 260 206 39 46
DIVALPROEX SODIUM 255 135 40 110
RANITIDINE HCL 243 192 41 56
ALPRAZOLAM 232 182 42 72
POLYETHYLENE GLYCOL 3350 232 191 42 62
LANTUS 229 114 44 49
CLONIDINE HCL 226 212 45 36
LANTUS SOLOSTAR 225 196 46 84
TRAMADOL HCL 225 186 46 18
ADVAIR DISKUS 225 200 46 53
JANUVIA 221 146 49 60
ISOSORBIDE MONONITRATE ER 215 204 50 59
KLOR-CON M10 214 191 51 127
LOSARTAN POTASSIUM 213 164 52 21
BENAZEPRIL HCL 210 165 53 40
SPIRIVA 206 179 54 70
BUMETANIDE 199 167 55 102
NOVOLIN N 191 149 56 225
LEVOFLOXACIN 191 157 56 97
PLAVIX 182 147 58 39
FAMOTIDINE 175 137 59 89
OLANZAPINE 170 93 60 116
DIGOXIN 168 139 61 58
CEFDINIR 165 110 62 212
PRAVASTATIN SODIUM 160 126 63 10
LEVETIRACETAM 157 107 64 120
SULFAMETHOXAZOLE-TRIMETHOPRIM 156 92 65 94
PANTOPRAZOLE SODIUM 153 114 66 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 151 125 67 37
AMLODIPINE BESYLATE-BENAZEPRIL 149 119 68 43
SEROQUEL 149 106 68 123
LEXAPRO 141 114 70 128
LIPITOR 140 93 71 68
ALLOPURINOL 138 100 72 33
FENOFIBRATE 137 98 73 66
ENALAPRIL MALEATE 137 118 73 65
PREDNISONE 133 103 75 50
DIVALPROEX SODIUM ER 128 65 76 148
CEPHALEXIN 119 108 77 149
BACLOFEN 117 84 78 140
ABILIFY 116 104 79 178
LYRICA 103 81 80 77
VENLAFAXINE HCL ER 103 28 80 101
LEVEMIR FLEXPEN 100 71 82 186
QUINAPRIL HCL 99 66 83 104
SYNTHROID 99 89 83 38
OXYBUTYNIN CHLORIDE 97 83 85 129
HYDRALAZINE HCL 97 80 85 71
CIPROFLOXACIN HCL 96 75 87 57
FLUTICASONE PROPIONATE 95 56 88 41
CARBIDOPA-LEVODOPA 94 90 89 117
FLUOXETINE HCL 92 74 90 74
SANTYL 92 56 90 170
LOSARTAN-HYDROCHLOROTHIAZIDE 91 71 92 51
CLOZAPINE 88 0 93 286
DETROL LA 85 65 94 169
FLUCONAZOLE 85 70 94 139
ALBUTEROL SULFATE 85 80 94 154
PROMETHAZINE HCL 85 44 R 94 96
BYSTOLIC 81 70 98 79
CYCLOBENZAPRINE HCL 78 38 R 99 81
GLIPIZIDE 78 52 99 63
NIFEDIPINE ER 77 62 101 75
BENICAR HCT 77 61 101 150
DOXYCYCLINE HYCLATE 76 66 103 95
LOVASTATIN 75 59 104 44
AMITRIPTYLINE HCL 74 57 R 105 47
EXELON 74 74 105 112
PHENYTOIN SODIUM EXTENDED 73 38 107 115
COMBIVENT 73 51 107 168
TRIAMTERENE-HCTZ 71 56 109 52
AZITHROMYCIN 71 49 109 42
CELEBREX 70 55 111 90
INSULIN SYRINGE 70 58 111 86
SPIRONOLACTONE 69 39 113 82
PEN NEEDLE 67 24 114 122
CARBAMAZEPINE 67 39 114 258
DOXAZOSIN MESYLATE 66 50 116 73
OLANZAPINE ODT 66 47 116 334
OXYBUTYNIN CHLORIDE ER 66 46 116 143
NOVOLIN R 65 37 119 113
AVODART 65 56 119 218
VYTORIN 64 64 121 152
PROAIR HFA 64 48 121 67
ONGLYZA 63 55 123 136
NOVOFINE AUTOCOVER 63 55 123 248
GLYBURIDE 62 62 R 125 85
SYMBICORT 61 23 126 208
ROPINIROLE HCL 60 53 127 99
MEGESTROL ACETATE 59 59 R 128 88
PROPRANOLOL HCL 59 51 128 145
NITROFURANTOIN MONO-MACRO 59 55 128 172
ACTOS 57 47 131 114
TRIAMCINOLONE ACETONIDE 57 53 131 199
VERAPAMIL ER 57 52 131 100
FENTANYL 57 45 S2 131 183
NYSTATIN 56 48 135 191
PAROXETINE HCL 55 51 136 76
ESTRADIOL 55 43 R 136 134
LATANOPROST 54 51 138 209
DORZOLAMIDE-TIMOLOL 53 53 139 299
HALOPERIDOL 52 30 140 193
BUSPIRONE HCL 52 48 140 144
METOCLOPRAMIDE HCL 52 21 140 118
LATUDA 51 17 143 369
TEMAZEPAM 51 45 143 155
DIOVAN HCT 50 43 145 55
FINASTERIDE 50 32 145 109
OXCARBAZEPINE 50 29 145 304
IPRATROPIUM-ALBUTEROL 50 32 145 207
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 17, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.